Trial intelligence / Profile preview

EPITHET: Alteplase in Acute Stroke

NCT00238537Phase 2Completed

Sponsor
Melbourne Health
Start
Aug 2001
Modality
rProtein (Recombinant Protein), Biologic
Countries
4
01

Overview

A Phase 2 trial of tissue-plasminogen activator in ischemic stroke, sponsored by Melbourne Health. Started Aug 2001; status: completed.

02

Drugs

tissue-plasminogen activator
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT00238537.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00238537.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call